| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.33 | 2e-05 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0005 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |